EP1231992A1 - Procede de separation de cellules et de biomolecules par chromatographie a contre-courant - Google Patents
Procede de separation de cellules et de biomolecules par chromatographie a contre-courantInfo
- Publication number
- EP1231992A1 EP1231992A1 EP00987272A EP00987272A EP1231992A1 EP 1231992 A1 EP1231992 A1 EP 1231992A1 EP 00987272 A EP00987272 A EP 00987272A EP 00987272 A EP00987272 A EP 00987272A EP 1231992 A1 EP1231992 A1 EP 1231992A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- separation
- modified
- biomolecules
- cells
- unmodified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 90
- 238000004185 countercurrent chromatography Methods 0.000 title claims abstract description 11
- 238000000926 separation method Methods 0.000 claims abstract description 112
- 230000003993 interaction Effects 0.000 claims abstract description 46
- 239000000463 material Substances 0.000 claims abstract description 42
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 238000010494 dissociation reaction Methods 0.000 claims abstract description 6
- 230000005593 dissociations Effects 0.000 claims abstract description 6
- 239000007787 solid Substances 0.000 claims abstract description 5
- 230000008569 process Effects 0.000 claims description 38
- 210000004027 cell Anatomy 0.000 claims description 27
- 239000000126 substance Substances 0.000 claims description 22
- -1 polyethylene Polymers 0.000 claims description 20
- 229920000642 polymer Polymers 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 229920002678 cellulose Polymers 0.000 claims description 8
- 239000004744 fabric Substances 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 210000000130 stem cell Anatomy 0.000 claims description 8
- 230000004048 modification Effects 0.000 claims description 7
- 238000012986 modification Methods 0.000 claims description 7
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000010980 cellulose Nutrition 0.000 claims description 6
- 229920002301 cellulose acetate Polymers 0.000 claims description 6
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- 229920001778 nylon Polymers 0.000 claims description 5
- 229920003023 plastic Polymers 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 5
- 229920000570 polyether Polymers 0.000 claims description 5
- 125000006850 spacer group Chemical group 0.000 claims description 5
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 4
- 229920002307 Dextran Polymers 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000003886 Glycoproteins Human genes 0.000 claims description 4
- 108090000288 Glycoproteins Proteins 0.000 claims description 4
- 230000000975 bioactive effect Effects 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 210000005259 peripheral blood Anatomy 0.000 claims description 4
- 239000011886 peripheral blood Substances 0.000 claims description 4
- 108010050934 polyleucine Proteins 0.000 claims description 4
- 239000004800 polyvinyl chloride Substances 0.000 claims description 4
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 239000007825 activation reagent Substances 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 230000033383 cell-cell recognition Effects 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 230000002093 peripheral effect Effects 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 230000004850 protein–protein interaction Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000004804 winding Methods 0.000 claims description 3
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 claims description 2
- IJABUNOZNNQRBR-UHFFFAOYSA-N 2-fluoro-1-methyl-2h-pyridine Chemical compound CN1C=CC=CC1F IJABUNOZNNQRBR-UHFFFAOYSA-N 0.000 claims description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- 239000004470 DL Methionine Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 2
- 229930186217 Glycolipid Natural products 0.000 claims description 2
- 102000002068 Glycopeptides Human genes 0.000 claims description 2
- 108010015899 Glycopeptides Proteins 0.000 claims description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 2
- 108090001090 Lectins Proteins 0.000 claims description 2
- 102000004856 Lectins Human genes 0.000 claims description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 2
- 239000002033 PVDF binder Substances 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 239000004693 Polybenzimidazole Substances 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 229920000297 Rayon Polymers 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 2
- 229910006501 ZrSiO Inorganic materials 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 235000020244 animal milk Nutrition 0.000 claims description 2
- 229920003235 aromatic polyamide Polymers 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- GRSTVVGJSKHCCS-UHFFFAOYSA-N bis(1h-imidazol-2-yl)methanone Chemical compound N=1C=CNC=1C(=O)C1=NC=CN1 GRSTVVGJSKHCCS-UHFFFAOYSA-N 0.000 claims description 2
- 239000010836 blood and blood product Substances 0.000 claims description 2
- 210000000601 blood cell Anatomy 0.000 claims description 2
- 229940125691 blood product Drugs 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 150000001718 carbodiimides Chemical class 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 229920006217 cellulose acetate butyrate Polymers 0.000 claims description 2
- 230000008859 change Effects 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims description 2
- 238000004132 cross linking Methods 0.000 claims description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims description 2
- 229940097362 cyclodextrins Drugs 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 238000009776 industrial production Methods 0.000 claims description 2
- 230000001788 irregular Effects 0.000 claims description 2
- 239000002523 lectin Substances 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 125000005395 methacrylic acid group Chemical group 0.000 claims description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 235000013379 molasses Nutrition 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 claims description 2
- 229920011301 perfluoro alkoxyl alkane Polymers 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 2
- 229920002492 poly(sulfone) Polymers 0.000 claims description 2
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920002480 polybenzimidazole Polymers 0.000 claims description 2
- 229920002857 polybutadiene Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920006393 polyether sulfone Polymers 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 2
- 229920001195 polyisoprene Polymers 0.000 claims description 2
- 229920000098 polyolefin Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 150000004760 silicates Chemical class 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 229920002873 Polyethylenimine Polymers 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 229910010293 ceramic material Inorganic materials 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 229920000414 polyfuran Polymers 0.000 claims 1
- 229920006380 polyphenylene oxide Polymers 0.000 claims 1
- 150000003457 sulfones Chemical class 0.000 claims 1
- 239000012530 fluid Substances 0.000 abstract description 3
- 238000004587 chromatography analysis Methods 0.000 description 13
- 239000000306 component Substances 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- 238000001042 affinity chromatography Methods 0.000 description 9
- 238000010828 elution Methods 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 239000005862 Whey Substances 0.000 description 6
- 102000007544 Whey Proteins Human genes 0.000 description 6
- 108010046377 Whey Proteins Proteins 0.000 description 6
- 239000003446 ligand Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000010445 Lactoferrin Human genes 0.000 description 5
- 108010063045 Lactoferrin Proteins 0.000 description 5
- 238000010924 continuous production Methods 0.000 description 5
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 5
- 229940078795 lactoferrin Drugs 0.000 description 5
- 235000021242 lactoferrin Nutrition 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 238000002299 affinity electrophoresis Methods 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- BYXHQQCXAJARLQ-ZLUOBGJFSA-N Ala-Ala-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O BYXHQQCXAJARLQ-ZLUOBGJFSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000003800 Selectins Human genes 0.000 description 1
- 108090000184 Selectins Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 108010046516 Wheat Germ Agglutinins Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 108010017893 alanyl-alanyl-alanine Proteins 0.000 description 1
- XBSNXOHQOTUENA-KRAHZTDDSA-N alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)C(O)O[C@@H]1CO XBSNXOHQOTUENA-KRAHZTDDSA-N 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000002045 capillary electrochromatography Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 238000011141 high resolution liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- LFKYBJLFJOOKAE-UHFFFAOYSA-N imidazol-2-ylidenemethanone Chemical compound O=C=C1N=CC=N1 LFKYBJLFJOOKAE-UHFFFAOYSA-N 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 238000000111 isothermal titration calorimetry Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000010070 molecular adhesion Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000005368 silicate glass Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 238000012932 thermodynamic analysis Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- SHIJTLJNEIRZOO-UHFFFAOYSA-N triethoxy(3-isothiocyanatopropyl)silane Chemical compound CCO[Si](OCC)(OCC)CCCN=C=S SHIJTLJNEIRZOO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28023—Fibres or filaments
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B11/00—Preservation of milk or dairy products
- A23B11/10—Preservation of milk or milk preparations
- A23B11/16—Preservation of milk or milk preparations by irradiation, e.g. by microwaves
- A23B11/164—Preservation of milk or milk preparations by irradiation, e.g. by microwaves by ultraviolet or infrared radiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1814—Recycling of the fraction to be distributed
- B01D15/1821—Simulated moving beds
- B01D15/185—Simulated moving beds characterised by the components to be separated
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1814—Recycling of the fraction to be distributed
- B01D15/1821—Simulated moving beds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
Definitions
- the invention relates to a method for the separation of cells and biomolecules from mixtures which contain these cells and biomolecules by means of continuous countercurrent chromatography with continuous sample application and removal using solid separation materials.
- chromatographic processes have already been developed for the purification of biological substances or substance mixtures. These include, for example, HPLC, anion exchange chromatography, gel filtration, affinity chromatography and hydrophobic matrix chromatography.
- These methods also include those that, for. B. work with affinity chromatography.
- mild application media are used, from which the substance to be obtained is removed by relatively strong binding to the separation medium.
- the subsequent selective detachment from the separation medium then always requires the use of a relatively drastic so-called elution medium, with the aid of which the substance sought can then be obtained in a second separate step.
- elution media are usually very rich in salt, and therefore the substances sought have to be freed from the salt load in a very complex manner.
- DE 1 9938394 A1 and DE 3930947 A1 describe affinity chromatography methods which use absorption on surfaces.
- the molecules to be separated such as antibodies, are covalently bound to the separation surfaces by means of strong bonds. Due to the strong connection to such surfaces, the selective detachment of the corresponding substances can only take place by using specific elution media, the substance previously bound to the support being detached by this elution medium in a second separate step. Thus, such methods cannot be used for continuous Chromatography methods, such as the countercurrent method described above, can be used.
- Continuous chromatographic processes have therefore already been developed in which the fluid to be chromatographed or a multicomponent mixture is fed continuously and the separated fractions are also continuously removed.
- Some of these are so-called countercurrent processes.
- a representative of such a countercurrent process is, for example, the so-called simulated moving bed process (SMB).
- SMB simulated moving bed process
- SMB simulated moving bed process
- TMB True Moving Bed
- the so-called True Moving Bed (TMB) process also belongs to these continuous countercurrent processes.
- the time-dependent chromatographic separation of the column chromatography is converted into a spatially resolved separation.
- This known countercurrent process mainly uses porous, particulate separation media.
- porous materials have always been used, as described, for example, in WO 9803242.
- the delaying effect that causes the separation of the biomolecules is a different flow of the molecules through the pores or past the pores, depending on the size of the molecule.
- Interactions are examples of such weak interactions.
- Weak interactions are understood to mean those bonds, which are typically typical of biomolecules, that are not covalent in nature and are relatively unstable, such as e.g. B. the already known hydrogen bonds, hydrophobic and electrostatic bonds and van der Waals forces.
- the description of such weak interactions, as are known for many interactions between biomolecules, can be thermodynamically with the aid of the "heat capacity difference" ( ⁇ C P ), as described in Cooper (A.
- the object of the present invention is accordingly to provide a method for separating cells and biomolecules from mixtures, in particular from complex mixtures, by means of countercurrent chromatography with continuous sample application and removal using solid non-porous separation materials, with which in the mixtures contained cells and biomolecules can be separated or separated, especially for production purposes and on an industrial scale.
- a core element of the method according to the invention is that the weak interactions described in the context of the present documents are used.
- the above-discussed dissociation constant K d which according to the invention is greater than or equal to 10 ⁇ 5 M, is used to define these weak interactions. This definition is therefore used in the context of the invention to characterize weak interactions.
- the process according to the invention is a continuous process or a continuous process which works according to the countercurrent process, with only a single liquid process Separation medium is used.
- Non-porous separating materials are understood to mean those materials that are already partially used in materials such as nylon, polystyrene, silicate glass (AL Plant et al., Immobilization of binding proteins on nonporous supports.
- Quartz fibers P. Wikstrom. Larsson PO, Affinity fiber - a new support for rapid enzyme purification by high-performance liquid affinity chromatography, J Chromatogr 1987, 388: 123-34.
- the applications described also did not relate to separations in which so-called weak interactions were used as the separation principle.
- the already known retarding effect due to diffusion processes which can be observed with porous materials, is used, but a completely different principle.
- a delaying effect is necessary in the method according to the invention for separating the molecules.
- this is achieved by the weak interactions described in more detail above, which the molecules to be separated enter into with the surfaces of the non-porous separation materials.
- the surfaces can either be modified or not modified.
- the appropriate selection of the surfaces or their modification ensures that the corresponding molecules to be separated are retained by molecular adhesion effects on the corresponding surfaces, as a result of which the molecules are separated.
- the degree of separation can be affected by the density of the corresponding molecular attachment sites.
- the process according to the invention which exploits the weak interactions described, has the advantage that the biomolecules can be separated without the use of drastic measures, for example high salt concentrations. High pressure differences can thus be avoided in the method according to the invention, so that a separation of cells from biological matrices can also be achieved.
- the separation takes place - as described - basically on surfaces that are formed on non-porous matrices or porous membranes.
- the method according to the invention can be used in particular for the industrial separation of biomolecules and cells.
- biomolecules proteins, carbohydrates, nucleic acids, glycoproteins, glycolipids, vitamins, enzymes, lipids and bioactive substances can be used as biomolecules.
- hormones and phytoestrogens are suitable as bioactive substances.
- the cells used are preferably those from plant, animal or unicellular cell sources or from peripheral blood. It may be necessary to use different separation matrices for certain molecules of these substance classes.
- the separation materials are selected in such a way that the weak interactions are sufficient to separate the substances from one another without them permanently adhering to the surfaces.
- the density of the release-active surface components or adhesion sites is preferably set such that no additions of salts are required for the separation.
- the method according to the invention is primarily intended for the separation of peripheral stem cells from the blood of human donors.
- the blood is preferably introduced directly into a device for carrying out the method according to the invention, which is described in more detail below, while the cells in question are retarded on the corresponding surfaces in such a way that the stem cells can be removed continuously from the device, while the other blood components in the can be removed substantially unchanged at other points in the device.
- cells which can be obtained from fermentations are preferably used as cells. It can be act plant, animal or unicellular organisms. According to the invention, primarily biomolecules and thus those molecules that come from biological sources are taken into account for the industrial separation processes. These biomolecules represent important starting products for the pharmaceutical industry and for the food industry. According to the invention, animal milk and dairy products, fermentation supernatants, molasses, plant extracts, residues from plant processing, blood products, wash water are therefore preferably used as the liquid to be chromatographed or as a multi-component mixture
- the separating materials used can have unmodified and also modified surfaces.
- the modification of surfaces is known per se and is used for the separation using porous, particulate separation media or using porous membranes.
- porous, particulate separation media or using porous membranes In contrast to
- Biological polymers are preferably used as separation materials with an unmodified surface. These preferably include celluloses, chitosans, dextrans,
- Modified biological polymers are also preferably used as separating materials. These preferably include modified celluloses such as cellulose acetates, carboxymethyicellulose,
- PVC polyvinyl chloride
- polyacrylonitrile polyaramid
- polystyrenes including styrene / divinylbenzene polymers
- polyester polypropylene
- teflone polypropylene
- PTFE teflone
- FEP FEP
- PFA polyvinyl alcohols
- polyvinylidene fluoride polyvinyl difluoride
- polyolefins methacrylic polymers
- polybenzimidazole polyfuranethylene
- polyphenols polyphenols
- Polybutadienes Polybutadienes, polybenzimidazolone, polyether / amide, polyether / urea, polyether viscose, polydimethylsiloxane, silicone, siloxanes, polycarbonate, polyalkylsulfone, polyisoprene, polyethylene terephthalate and mixtures of two or more of these plastics.
- modified and unmodified inorganic matrices are preferably used, these being, in particular, biocompatible materials such as carbon / carbon fiber composites, ceramics (TiO 2 , Al 2 O 3 , ZrSiO 4 , ZrO 2 ), silicates, glasses and other matrices (e.g. Fabrics made of metal wire or glass fiber with or without surface modification), which are typical for chemical apparatus construction. It must also be taken into account here that the biomolecules and cells to be separated do not penetrate through or into the surfaces in order to avoid the possibility of uncontrolled absorption and unwanted pressure drops.
- the modification of the separation materials (more precisely the surfaces thereof) can be carried out using methods known per se.
- the possible methods of modification preferably include chemical linking (cross-linking).
- Groups present on the polymers for example hydroxyl, carboxy, carboxyl, amino, amide, aryl, sulfhydryl, alkyl, methoxy and ethoxy radicals or groups, are activated by methods known per se as described, for example, in: E. Müller, E. Klein “Membranes Modified for Biochromatography” in: Bioseparation and Bioprocessing. Vol 1 (Editor: G. Subramanian), Wiley-VCH, Weinheim 1 997.
- the required ligands are covalently bound to the surfaces, and the activation methods which can be used according to the invention include, for example, methods in which the following activation reagents are used: cyanogen bromide, tosyl chloride, N-hydroxy succinimide, carbonyl-di-imidazole, carbodiimides, 1, 4 -Butanediol-diglycidol ether, glutaraldehyde and 2-fluoro-1-methylpyridine If desired, so-called spacers can be introduced as attachment sites or binding sites for the weak interaction Can then attach to the activated surfaces preferably the following biomolecules are bound: polymeric carbohydrates (e.g.
- chitosans and dextrans glycoproteins, glycopeptides, glycans, lectins, polymerized amino acids (e.g. poly-L-leucine), peptides, proteins, nucleotides and biomolecule-binding dyes.
- the geometry of the surfaces of the separating materials on which the separation takes place can be designed in a very varied manner.
- the separating materials are washed or flushed by the liquid to be chromatographed.
- So z. B smooth surfaces in the smallest possible distances in the form of narrow channels or tubes.
- Flexible hoses with small diameters can also be used.
- spacers in the form of threads nets or precision fabrics are preferably inserted between the surfaces. These spacers can be made of the same material as the surfaces of the separating materials.
- tubes, hoses or winding units made of an inert material can also be used, in the lumens of which there are threads, nets or wick-like fabrics, the surface of which is as previously described.
- Irregular filter shapes such as molten metal filters (e.g. from Drache, Dietz, FRG), which have a large surface area and are made of ceramic, chemically and thermally highly stressable material can also be used. The liquid flows run past these surfaces and do not penetrate them. Since the liquid flows do not encounter large resistances, large pressure drops can be avoided. This means that pumps and valves can also be used that are sufficient for medium pressure conditions and also less expensive than is the case for high-pressure equipment.
- the device for carrying out the method according to the invention is provided with several so-called separation units, in which there are separating materials.
- the separation units are at least chromatographically essentially the same and preferably essentially identical.
- the separating materials used are preferably approximately the same in terms of shape, size and type and preferably essentially identical.
- a plurality of separation units are preferably connected in series in terms of flow and combined to form separation zones.
- valve units which are controlled by a computer and whose position is changed using a mathematical model, so that the weak separation effect based on the interactions is optimized in such a way that the separation of the substances can be done continuously.
- the material flows are carried in and out with the aid of several and typically four pumps.
- the flow and circulatory system which is maintained by another pump, is designed like SMB chromatography. There are therefore several separation zones, each of which is assigned a certain number of separation units and which are coupled to the corresponding lines by valve circuits.
- the separation method according to the invention which uses the weak interaction mentioned and in which the separation takes place on non-porous surfaces, can also be carried out as computer-controlled countercurrent chromatography by separation on surfaces or in English “Computer controlled counter current chromatography using separation on surfaces” or abbreviated “ C-5-S-2 ". Only the term “C-5-S-2" is used below.
- FIG. 1 shows the structure of a device for performing the method according to the invention in a highly simplified and very schematic manner, numerous details being omitted in order to be able to illustrate the principle of the method according to the invention more clearly and simply.
- the structure and the control shown there are - as shown - of a known type. In this regard, reference is made to the publications mentioned above.
- the individual separation units A, B, C, D, E, F, G and H of the device shown in Fig. 1 are connected in series in terms of flow. Between these individual separation units there are inflows and outflows 1, 2, 3, 4, 5, 6, 7 and 8 to a large valve unit 10.
- the inflows and outflows 1 to 8 each have an inflow and an outflow; for the sake of simplicity, the two lines are only shown with a line 1 to 8 in the figure.
- the valve unit 10 is computer-controlled and equipped with two inflows 21 and 22 and two outlets 23 and 24, with one inflow 21 for each Separation medium and an inlet 22 for the mixture to be separated and an outlet 23 for component 1 and an outlet 24 for component 2 are present.
- two separation units A, B; C, D; E, F and G, H connected to separation zones AB, CD, EF and GH.
- the inflows and outflows are switched in such a way by the valve arrangement that an inflow and outflow always alternate.
- the first separation zone AB is thus between the inflow of the separation medium and the outflow of component 2 (extract).
- the second separation zone CD is located between the outflow of component 2 (extract) and the inflow of the mixture to be separated.
- the third zone EF is here between the supply of the mixture to be separated and the outflow of component 1 (raffinate).
- the fourth zone GH is located between the outflow of component 1 (raffinate) and the inflow of the separation medium.
- two separation units are connected to a separation zone.
- this type of circuit is only one embodiment.
- the separation units can also be used alone or connected in groups of three, four, etc.
- the central fourfold distributor valve unit 1 0 is controlled with the aid of a computer program and can have different mechanical structures.
- it can be designed as a rotary multiple valve or can be constructed from several triple or single valves. It is only important that the valves are opened and closed in such a way that the separation zones AB, CD, EF and GH are switched on in the direction of flow of the mobile or liquid phase in such a way that a quasi counterflow to the solid phase is generated.
- the pumps are preferably controlled by a computer program in such a way that the flow rates in the separation zones are regulated in such a way that only the pure components 1 and 2 are discharged. It is a complex controlled process in which the suitable parameters are expediently determined by computer simulation.
- the separation units are manufactured as follows:
- Teflon tubing 8 mm in diameter is terminated at a length of 40 centimeters at the ends with stainless steel nets, and the tapered ends are each connected to pumps or valves with thinner tubing.
- a wick-like nylon fabric is inserted between the ends as a separating material, on which the glycan sialyl-Lewis A is coupled as an adhesion phase by activation with cyanuric chloride and dicyclohexylcarbodiimide.
- the group density was chosen so that less than 0.1 ⁇ mol of the ligand is bound per gram of nylon.
- Such a piece of Teflon tubing represents a separation unit. A total of 8 separation units are connected in series, the separation zones each consisting of 2,2,3,1 units.
- Separation zone 1 (separation medium / stem cell extract) consists of 2 units.
- Separation zone 2 (stem cell extract / blood flow) consists of 2 units.
- Separation zone 3 (blood inflow / blood outflow) consists of 3 units.
- Separation zone 4 (blood drain / separation medium) consists of 1 unit. Isotonic saline is used as the separation medium. The entire apparatus is heated to 37 degrees Celsius.
- Example 2 In this way it is possible to obtain around 10 million stem cells from the peripheral blood of a donor within 2 hours.
- Example 2
- Lactoferrin is separated from cow whey using the C-5-S-2 process.
- the separation units are manufactured as follows. Spacers (nets made of woven cellulose acetate fibers of 0.5 mm diameter) are inserted into tubes of 50 mm diameter made of cellulose acetate and wound flat on cores in lengths of 3 m. The tubing is non-porous and the ends are each sealed and tapered with plastic frit so that the appropriate inflow and outflow tubing can be connected to the units.
- the cellulose acetate surfaces are activated with the aid of 1.1 carbonylimidazole and chitosans are covalently bound to them.
- the group density is approximately 1.0 mmol per gram of cellulose acetate.
- Separation zone 1 (separation medium / lactoferrin outflow) is 1 unit, separation zone 2 (lactoferrin outflow / inflow whey) 4 units, separation zone 3 (inflow whey / outflow residual whey) 4 units and separation zone 4 (outflow residual whey / separation medium) ) 1 unit in size.
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
L'invention concerne un procédé de séparation de cellules et de biomolécules à partir de mélanges comprenant ces cellules et ces biomolécules. A cet effet, on utilise la chromatographie à contre-courant avec alimentation et prélèvement permanents d'échantillons et utilisation de matériaux de séparation solides et non poreux. Le procédé est caractérisé en ce qu'un seul matériau de séparation est utilisé, de manière à éviter tout changement de ce matériau, en ce que les matériaux de séparation non poreux utilisés ont une surface modifiée ou non modifiée, et en ce que, pour la séparation des cellules et des biomolécules à séparer, des « interactions faibles » sont mises en oeuvre et résultent de la mise en contact des cellules et des biomolécules à séparer avec la surface modifiée ou non modifiée. Par interactions faibles, il faut comprendre celles dont les liaisons ont une constante de dissociation égale ou supérieure à 10-5 M (Kd ≥ 10-5 M).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19956010 | 1999-11-20 | ||
| DE19956010 | 1999-11-20 | ||
| PCT/EP2000/011520 WO2001037959A1 (fr) | 1999-11-20 | 2000-11-20 | Procede de separation de cellules et de biomolecules par chromatographie a contre-courant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1231992A1 true EP1231992A1 (fr) | 2002-08-21 |
Family
ID=7929832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00987272A Withdrawn EP1231992A1 (fr) | 1999-11-20 | 2000-11-20 | Procede de separation de cellules et de biomolecules par chromatographie a contre-courant |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1231992A1 (fr) |
| AU (1) | AU2358101A (fr) |
| WO (1) | WO2001037959A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1545574B8 (fr) * | 2002-09-13 | 2014-09-24 | Biogen Idec Inc. | Procede de purification de polypeptides par chromatographie sur lit mobile simule |
| DE102006028129B4 (de) * | 2006-06-15 | 2008-07-03 | Nikolaus Stephan Pfeiffer | Kontinuierliche Gegenstom Chromatographie Anlage |
| CN101678244B (zh) | 2007-04-17 | 2013-06-19 | 深度控股有限公司 | 用于连续膜吸附的方法和装置 |
| CN103736296B (zh) * | 2013-12-30 | 2015-12-30 | 浙江大学 | 一种制备丹参酮化合物的双柱循环分离系统及其方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE468653B (sv) * | 1987-03-06 | 1993-02-22 | Perstorp Biolytica | Adsorbent foer isokratisk affinitetskromatografi |
| DE3900272A1 (de) * | 1989-01-07 | 1990-07-12 | Mueller Schulte Detlef Dr | Synthetisches polymeres traegermaterial fuer chromatographische trennverfahren, verfahren zu seiner herstellung und verwendung |
| GB2274843B (en) * | 1993-02-09 | 1997-02-26 | Agricultural & Food Res | Continuous separation and purification of materials |
| US5482631A (en) * | 1994-10-06 | 1996-01-09 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Separation of inositols from sugars and sugar alcohols |
| DE19629208A1 (de) * | 1995-01-20 | 1998-01-22 | Merck Patent Gmbh | Verwendung von modifizierten Membranen für "Simulated Moving Bed" Trennverfahren |
| US5645729A (en) * | 1995-02-13 | 1997-07-08 | Uop | Separations by simulated moving bed chromatography operating at low k' values using weakly interacting adsorbents as the stationary phase |
| US5626762A (en) * | 1995-02-13 | 1997-05-06 | Uop | Separations by simulated moving bed chromatography operating at low K' values using weakly interating adsorbents as the stationary phase |
-
2000
- 2000-11-20 EP EP00987272A patent/EP1231992A1/fr not_active Withdrawn
- 2000-11-20 AU AU23581/01A patent/AU2358101A/en not_active Abandoned
- 2000-11-20 WO PCT/EP2000/011520 patent/WO2001037959A1/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0137959A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2358101A (en) | 2001-06-04 |
| WO2001037959A1 (fr) | 2001-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Avramescu et al. | Preparation of mixed matrix adsorber membranes for protein recovery | |
| Avramescu et al. | Mixed-matrix membrane adsorbers for protein separation | |
| DE60203176T2 (de) | Fraktionierung von proteinhaltigen mischungen | |
| DE69807240T2 (de) | Gussmembranstruktur zur probenaufbereitung | |
| Borneman et al. | Enzyme capturing and concentration with mixed matrix membrane adsorbers | |
| EP3442700B1 (fr) | Adsorbant multimodal comportant des ligands multimodaux, son procédé de préparation et son utilisation | |
| EP3347125B1 (fr) | Milieu d'adsorption, procédé pour le préparer et son utilisation pour purifier des biomolécules | |
| DE10236664B4 (de) | Verfahren und Vorrichtung zur adsorptiven Stofftrennung | |
| US5466377A (en) | Chromatography media and their uses | |
| Avramescu et al. | Particle-loaded hollow-fiber membrane adsorbers for lysozyme separation | |
| DE3882797T2 (de) | Schwach affinitives Adsorbens für Affinitätschromatographie. | |
| EP1140316A1 (fr) | Procede continu de separation de matieres selon la taille des molecules | |
| WO2012057676A1 (fr) | Système de chromatographie comportant des colonnes de garde | |
| EP3167283B1 (fr) | Dispositif, utilisation dudit dispositif, et procédé servant à séparer des substances en exploitant mieux la capacité de milieux chromatographiques | |
| US20060070955A1 (en) | Method and apparatus for separating a target molecule from a liquid mixture | |
| Avramescu et al. | Dynamic behavior of adsorber membranes for protein recovery | |
| Li et al. | Expanded bed adsorption/desorption of proteins with Streamline Direct CST I adsorbent | |
| DE60222243T2 (de) | Trennmittel für optisches isomer | |
| EP0921847B1 (fr) | Utilisation de sorbants non particulaires pour des procedes de separation a "lit mobile simule" | |
| WO2001037959A1 (fr) | Procede de separation de cellules et de biomolecules par chromatographie a contre-courant | |
| US7413660B2 (en) | Single pass method and apparatus for separating a target molecule from a liquid mixture | |
| EP0968038B1 (fr) | Procede et installation pour separation de matieres par adsorption | |
| EP4493199B1 (fr) | Méthodes et compositions de purification de petites vésicules extracellulaires | |
| EP2521607B1 (fr) | Procédé de qualification d'un adsorbant échangeur d'ions non particulaire | |
| EP0912242A1 (fr) | Sorbants non particulaires chirals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20020605 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| 17Q | First examination report despatched |
Effective date: 20021014 |
|
| RBV | Designated contracting states (corrected) |
Designated state(s): AT DE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20041013 |